Nuvectis Pharma, Inc. (NVCT)

Typically moves ±6.09% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-04 APPROXIMATE

Nuvectis Pharma, Inc. (NVCT) has a 19-report earnings history dating back to Mar 22, 2022. Its average absolute post-earnings move is ±6.09%, and 42.1% of those reactions were positive. Its largest post-earnings gain was +17.75% (Nov 05, 2024) and its largest decline was -7.83% (Nov 08, 2023). The next earnings report is predicted for 2026-11-04 (approximate).

Earnings reactions

How NVCT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.09%

Positive %

42.1%

Negative %

57.9%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 04, 2026	☀ PRE	-6.8%	open_in_new
May 05, 2026	☀ PRE	+10.01%	open_in_new
Feb 11, 2026	☀ PRE	+0.46%	open_in_new
Nov 04, 2025	☀ PRE	-7.55%	open_in_new
Aug 05, 2025	☀ PRE	-5.35%	open_in_new
May 06, 2025	☀ PRE	-4.38%	open_in_new
Feb 25, 2025	☀ PRE	-5.84%	open_in_new
Nov 05, 2024	☀ PRE	+17.75%	open_in_new
Aug 06, 2024	☀ PRE	-5.83%	open_in_new
May 07, 2024	☀ PRE	-4.89%	open_in_new
Mar 05, 2024	☀ PRE	-0.97%	open_in_new
Nov 08, 2023	☀ PRE	-7.83%	open_in_new
Aug 09, 2023	☽ POST	+0.4%	open_in_new
May 15, 2023	☀ PRE	+6.2%	open_in_new
Mar 07, 2023	☽ POST	-2.47%	open_in_new
Nov 08, 2022	☀ PRE	+0.85%	open_in_new
Aug 05, 2022	☀ PRE	-1.16%	open_in_new
May 11, 2022	☽ POST	+12.54%	open_in_new
Mar 22, 2022	☀ PRE	+14.43%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.09%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 17 →

Funds holding

$29871196

Total value held

Buying

12 added · 5 reduced

Blackrock, Inc.

$18413632 +30.98%

State Street Corp

$4564361 +49.05%

Northern Trust Corp

$2698071 +18.12%

Ubs Group Ag

$1272588 NEW BUY

Bank Of New York Mellon Corp

$676192 +21.29%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
EFFECT	20260828	open_in_new SEC.gov
8-K	20260821	open_in_new SEC.gov
S-3	20260821	open_in_new SEC.gov
SCHEDULE 13G	20260806	open_in_new SEC.gov
4	20260805	open_in_new SEC.gov
10-Q	20260804	open_in_new SEC.gov
8-K	20260804	open_in_new SEC.gov
4	20260701	open_in_new SEC.gov
4	20260701	open_in_new SEC.gov
424B5	20260630	open_in_new SEC.gov

Frequently asked about NVCT earnings

When does Nuvectis Pharma, Inc. report earnings next? expand_more

Nuvectis Pharma, Inc. (NVCT)'s next earnings date is approximate for 2026-11-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does NVCT stock move after earnings? expand_more

Over 19 reports, NVCT has moved an average of ±6.09% the session after earnings, closing higher 42.1% of the time.

What was NVCT's biggest post-earnings move? expand_more

NVCT's largest post-earnings gain on record was +17.75% on Nov 05, 2024, and its largest decline was -7.83% on Nov 08, 2023.

Where can I find Nuvectis Pharma, Inc.'s SEC filings? expand_more

All of Nuvectis Pharma, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.